Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Betamethasone Valerate
Generic Name
Betamethasone Valerate
Active Ingredient
BetamethasoneCategory
Other
Salt Form
Valerate
Variants
21
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 mg/g | CREAM | TOPICAL | 68071-4278 |
| 1 mg/g | CREAM | TOPICAL | 0168-0040 |
| 1.2 mg/g | AEROSOL, FOAM | TOPICAL | 45802-053 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Betamethasone Valerate, you must consult a qualified healthcare professional.
| 1 mg/g | CREAM | TOPICAL | 50090-1647 |
| 1 mg/g | CREAM | TOPICAL | 50090-3134 |
| 1 mg/g | CREAM | TOPICAL | 68788-7451 |
| 1 mg/g | OINTMENT | TOPICAL | 68788-8496 |
| 1 mg/g | OINTMENT | TOPICAL | 0168-0033 |
| 1.2 mg/g | CREAM | TOPICAL | 50090-4696 |
| 1 mg/g | CREAM | TOPICAL | 51672-1269 |
| 1 mg/g | CREAM | TOPICAL | 71205-040 |
| 1 mg/g | CREAM | TOPICAL | 68788-8450 |
+ 9 more variants
Detailed information about Betamethasone Valerate
Betamethasone is a potent corticosteroid used to treat a wide variety of inflammatory and autoimmune conditions, including skin disorders, allergic reactions, and rheumatic diseases. It works by suppressing the immune system and reducing the production of inflammatory chemicals in the body.
The dosage of betamethasone is highly individualized and depends on the specific condition being treated, its severity, and the patient's response to therapy.
Betamethasone must be used with extreme caution in children. Corticosteroids can interfere with growth and development.
While betamethasone is primarily metabolized by the liver, its metabolites are excreted by the kidneys. Generally, no specific dose adjustment is required for patients with renal failure, but these patients should be monitored for fluid retention, as corticosteroids can cause the body to hold onto sodium and water.
Since the liver is the primary site of betamethasone metabolism, patients with severe liver disease (such as cirrhosis) may experience higher levels of the drug in their system. A lower dose or less frequent administration may be necessary to prevent toxicity. Healthcare providers will monitor these patients closely for signs of corticosteroid excess (Cushingoid features).
Older adults should be started on the lowest possible dose. They are at higher risk for side effects such as osteoporosis (bone thinning), hypertension (high blood pressure), and skin thinning. In the elderly, the risk of topical steroid-induced skin atrophy (bruising and tearing) is significantly higher.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up. If you miss multiple doses of systemic betamethasone, contact your healthcare provider immediately, as sudden discontinuation can be dangerous.
An acute overdose of betamethasone is unlikely to be life-threatening. However, chronic overdose (using too much over a long period) can lead to 'Cushing’s Syndrome,' characterized by a moon-shaped face, weight gain in the trunk, and thinning skin. If someone swallows topical betamethasone or takes an excessive oral dose, contact a poison control center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as stopping systemic steroids suddenly can cause a life-threatening adrenal crisis.
Side effects of betamethasone vary based on the route of administration. For topical use, the most common side effects are localized to the site of application. These include:
For systemic use (oral or injection), common effects include:
Betamethasone is a potent medication that must be used under strict medical supervision. It is not a 'simple' anti-itch cream or a standard painkiller; it affects nearly every organ system in the body. Patients must be aware that the effects of betamethasone can persist for several days after the last dose due to its long biological half-life. It should never be shared with others, even if they have similar symptoms, as the risks of inappropriate steroid use are high.
No FDA black box warnings for Betamethasone. However, this does not imply the drug is without risk. The primary safety concerns involve the suppression of the body's natural immune and endocrine functions.
There are certain situations where betamethasone must never be used because the risk of harm far outweighs any potential benefit:
Betamethasone is classified by the FDA as Pregnancy Category C. This means that animal studies have shown adverse effects on the fetus (such as cleft palate and intrauterine growth restriction), but there are no adequate, well-controlled studies in humans.
Betamethasone is a potent glucocorticoid with negligible mineralocorticoid activity. Its primary mechanism involves the modulation of gene expression. Upon entering the target cell, it binds to the glucocorticoid receptor (GR). This complex translocates to the nucleus, where it binds to Glucocorticoid Response Elements (GRE). This leads to the induction of lipocortins, which inhibit phospholipase A2. By inhibiting this enzyme, betamethasone prevents the release of arachidonic acid from cell membranes, thereby shutting down the production of both prostaglandins (via the COX pathway) and leukotrienes (via the LOX pathway). Additionally, it suppresses the expression of various adhesion molecules and cytokines, effectively preventing white blood cells from exiting the bloodstream and entering inflamed tissues.
The anti-inflammatory effects of betamethasone are dose-dependent. Following systemic administration, the onset of action is generally within 1–3 hours, but the peak anti-inflammatory effect may take several days of consistent dosing to achieve. Because betamethasone is a 'long-acting' steroid, its effects on the hypothalamic-pituitary-adrenal (HPA) axis persist long after the drug has been cleared from the blood. Tolerance (tachyphylaxis) can occur with topical use, where the skin becomes less responsive to the drug over time; this is why 'pulse therapy' (using the drug for a few days on and a few days off) is often recommended for chronic skin conditions.
Common questions about Betamethasone Valerate
Betamethasone is a potent corticosteroid used to treat a wide range of conditions characterized by inflammation and overactive immune responses. Topically, it is frequently prescribed for skin conditions such as psoriasis, severe eczema, and various types of dermatitis to reduce redness, itching, and swelling. Systemically, it is used for rheumatic disorders like rheumatoid arthritis, severe allergic reactions, and endocrine issues. It is also used in specialized cases, such as helping mature a fetus's lungs if preterm birth is expected. Because it is highly potent, it is typically reserved for cases where milder steroids have failed. Always use it under the direction of a healthcare professional for the specific condition diagnosed.
The side effects of betamethasone depend on how it is administered. For topical forms like creams or ointments, common side effects include localized burning, stinging, itching, or thinning of the skin (atrophy) at the application site. Systemic forms (pills or injections) commonly cause increased appetite, weight gain, insomnia, and mood changes such as irritability. Some patients also experience fluid retention, which can lead to swelling in the ankles or feet. Long-term use of any form can lead to more serious issues like bone thinning or a suppressed immune system. It is important to report any persistent or worsening side effects to your doctor immediately.
There is no known direct chemical interaction between betamethasone and alcohol; however, caution is strongly advised. Alcohol can increase the risk of stomach irritation and peptic ulcers, which are already potential side effects of systemic corticosteroids. Additionally, both alcohol and steroids can affect mood and sleep patterns, potentially worsening the psychiatric side effects of the medication. For those using betamethasone for conditions like psoriasis, alcohol is also a known trigger that can cause flare-ups, potentially making the treatment less effective. It is best to discuss your alcohol consumption habits with your healthcare provider to ensure safety. Generally, limiting alcohol is recommended during treatment.
Betamethasone is generally used during pregnancy only when the potential benefit justifies the potential risk to the fetus, as it is classified as Category C. While it is a standard and life-saving treatment used short-term to help develop a premature baby's lungs, chronic use throughout pregnancy carries risks. Long-term use may lead to reduced birth weight or 'fetal adrenal suppression,' where the baby is born with underactive adrenal glands. Animal studies have also suggested a link to oral clefts when used in the first trimester. If you are pregnant or planning to become pregnant, your doctor will perform a careful risk-benefit analysis. Always inform your obstetrician if you are using any form of betamethasone.
The time it takes for betamethasone to work varies by the condition being treated and the form used. For topical applications on skin conditions like eczema, many patients notice a reduction in itching and redness within 24 to 48 hours. For systemic injections or oral tablets used for acute allergic reactions, the drug begins to work within 1 to 3 hours, though its peak effect may take a day or more. In chronic conditions like rheumatoid arthritis, it may take several days of consistent use before the full anti-inflammatory benefits are felt. If you do not see any improvement in your symptoms after two weeks of use, you should consult your healthcare provider. Do not continue using high-potency steroids longer than prescribed.
You should never stop taking systemic betamethasone (pills or injections) suddenly if you have been using it for more than a few days. Doing so can cause 'steroid withdrawal' or an adrenal crisis because your body has stopped making its own natural cortisol while on the medication. Symptoms of an adrenal crisis include severe weakness, fatigue, dizziness, and very low blood pressure, which can be life-threatening. Your doctor will provide a tapering schedule to gradually lower your dose, allowing your adrenal glands to restart their natural production. For topical use, stopping suddenly can sometimes cause a 'rebound' flare-up of the skin condition. Always follow the specific discontinuation instructions provided by your medical professional.
If you miss a dose of betamethasone, you should take or apply it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and continue with your regular timing. Never 'double up' or use extra medication to make up for a missed dose, as this increases the risk of side effects. For systemic doses, missing multiple doses can be dangerous and may lead to withdrawal symptoms, so you should contact your doctor if this happens. For topical use, simply resume your normal application schedule. Consistency is key to managing the inflammation effectively, so try to use the medication at the same time each day.
Weight gain is a well-documented side effect of systemic betamethasone, especially with long-term oral or injectable use. This occurs because corticosteroids increase appetite and can cause the body to redistribute fat to the face (moon face), neck (buffalo hump), and abdomen. Additionally, the drug causes the body to retain sodium and water, leading to fluid weight and bloating. Topical betamethasone is much less likely to cause weight gain unless it is used over very large areas of the body for a long time, allowing for significant systemic absorption. If you are concerned about weight changes, talk to your doctor about dietary adjustments, such as reducing salt intake, to help manage these effects.
Betamethasone can interact with many other medications, so it is vital to provide your doctor with a full list of everything you take. It can interact seriously with blood thinners like warfarin, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, and certain diuretics. It also opposes the action of diabetes medications, meaning your blood sugar may rise and require dose adjustments of your insulin or oral pills. Some antifungal medications and antibiotics can slow down the metabolism of betamethasone, increasing the risk of toxicity. Even herbal supplements like St. John's Wort can interfere with how the drug works. Your pharmacist can check for specific drug-drug interactions based on your current prescriptions.
Yes, betamethasone is widely available as a generic medication in almost all of its forms, including betamethasone valerate and betamethasone dipropionate. Generic versions are typically much more cost-effective than brand-name versions like Luxiq or Celestone. The FDA requires generic medications to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug, ensuring they are bioequivalent. Availability may vary depending on the specific salt and concentration required for your condition. You can ask your healthcare provider or pharmacist if a generic version is appropriate for your prescription to help manage your healthcare costs while receiving the same therapeutic benefit.
Other drugs with the same active ingredient (Betamethasone)
> Warning: Stop taking Betamethasone and call your doctor immediately if you experience any of the following:
Prolonged use of betamethasone (longer than 2–4 weeks for topical or systemic use) can lead to significant complications:
Currently, there are no FDA black box warnings specifically for betamethasone. However, the FDA requires class-wide warnings for all potent corticosteroids regarding the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression and the potential for systemic absorption from topical products. Healthcare providers are warned that pediatric patients may be more susceptible to systemic toxicity from equivalent doses due to their larger skin surface area to body mass ratios.
Report any unusual symptoms to your healthcare provider. Monitoring through regular blood tests and physical exams is essential for long-term therapy.
If you are on long-term betamethasone therapy, your healthcare provider will likely require regular monitoring, including:
Betamethasone generally does not interfere with the ability to drive or operate machinery. However, if you experience side effects like blurred vision, dizziness, or significant mood changes, you should avoid these activities until you know how the medication affects you.
While there is no direct chemical interaction between betamethasone and alcohol, drinking alcohol while taking systemic steroids can increase the risk of gastrointestinal irritation and peptic ulcers. It may also worsen the mood-altering effects of the medication. It is generally advised to limit alcohol consumption during treatment.
Never stop taking systemic betamethasone abruptly. If you have been taking the drug for more than a few days, your body has likely slowed down its own production of cortisol. Stopping 'cold turkey' can lead to an adrenal crisis, which is a medical emergency characterized by low blood pressure, dehydration, and vascular collapse. Your doctor will provide a 'tapering schedule' to slowly reduce the dose over weeks or months, allowing your adrenal glands to wake up and resume normal function.
> Important: Discuss all your medical conditions, especially any history of tuberculosis, herpes, or mental health issues, with your healthcare provider before starting Betamethasone.
Betamethasone can interfere with several laboratory tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even topical products can interact if they are absorbed into the bloodstream.
In these conditions, betamethasone should only be used if the healthcare provider determines the benefits are essential, and even then, with extreme caution:
Patients who are allergic to one corticosteroid may be allergic to others. This is known as cross-sensitivity. Corticosteroids are often grouped into classes (A, B, C, and D) based on their chemical structure. Betamethasone is in Class C (Betamethasone group). Patients who have a contact allergy to topical betamethasone valerate may also react to dexamethasone or fluticasone. Always inform your provider if you have ever had a skin rash or reaction to any steroid cream or pill.
> Important: Your healthcare provider will evaluate your complete medical history, including past infections and mental health, before prescribing Betamethasone.
Corticosteroids are generally avoided in children unless absolutely necessary.
Elderly patients are more likely to experience the 'toxic' effects of steroids.
While the drug is not significantly removed by hemodialysis, the metabolic byproducts can accumulate. The main concern in renal impairment is the mineralocorticoid effect—the tendency of the drug to cause the body to hold onto salt and water, which can be dangerous for patients with kidney failure who cannot easily eliminate fluids.
In patients with severe liver disease, the liver's ability to metabolize betamethasone is reduced. This leads to a longer half-life and higher systemic levels of the drug. These patients are at a much higher risk for developing Cushingoid symptoms and must be monitored for signs of steroid excess even on 'standard' doses.
> Important: Special populations require individualized medical assessment and often more frequent follow-up appointments.
| Parameter | Value |
|---|---|
| Bioavailability | Oral: ~70-90%; Topical: Variable (1-15%) |
| Protein Binding | ~64% (primarily to Albumin) |
| Half-life | Plasma: 6.5 hours; Biological: 36-54 hours |
| Tmax | Oral: 1-2 hours; IM: 1-3 hours |
| Metabolism | Hepatic (Primary: CYP3A4) |
| Excretion | Renal: >95%; Fecal: <5% |
Betamethasone is classified as a high-potency (Group 2 or 3 depending on the salt) topical corticosteroid or a long-acting systemic glucocorticoid. It is in the same therapeutic class as dexamethasone. It differs from 'short-acting' steroids like hydrocortisone and 'intermediate-acting' steroids like prednisone primarily in its duration of HPA axis suppression and its lack of sodium-retaining effects.